Short-term E-cigarette exposure increases the risk of thrombogenesis and enhances platelet function in mice

Journal of the American Heart Association

Volumn 7, Issue 15, 2018, Pages

  Qasim, Hanan ^a   Karim, Zubair A ^a   Silva Espinoza, Juan C ^a   Khasawneh, Fadi T ^a   Rivera, José O ^a   Ellis, Cameron C ^a   Bauer, Stephanie L ^a   Almeida, Igor C ^a   Alshbool, Fatima Z ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

Author keywords

Cardiovascular disease; E cigarettes; E vaping; Electronic nicotine delivery systems; Platelet; Thrombosis

Indexed keywords

ALPHA2B BETA3 INTEGRIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLSERINE; PROSTACYCLIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; C57BL 6 MOUSE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE ACTIVATION; HEMOSTASIS; IN VIVO STUDY; LEUKOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PASSIVE SMOKING; PLATELET COUNT; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOSIS; ADVERSE EVENT; ANIMAL; BLOOD; BLOOD CLOTTING PARAMETERS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; FOLLOW UP; PHYSIOLOGY; RISK FACTOR; SMOKING; THROMBOCYTE; TIME FACTOR; VAPING;

ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FOLLOW-UP STUDIES; MALE; MICE; MICE, INBRED C57BL; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; RISK FACTORS; SMOKING; THROMBOSIS; TIME FACTORS; VAPING;

EID: 85051433473     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.118.009264     Document Type: Article

References (110)

1. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2010.
2. General ARotS. E-cigarette use among youth and young adults. 2016.
3. cdc e-cigs and youth 2016 (002).Pdf.
4. Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. 2015;33: 952-963.
5. Patel D, Davis KC, Cox S, Bradfield B, King BA, Shafer P, Caraballo R, Bunnell R. Reasons for current e-cigarette use among U.S. adults. Prev Med. 2016;93: 14-20.
6. Qasim H, Karim ZA, Rivera JO, Khasawneh FT, Alshbool FZ. Impact of electronic cigarettes on the cardiovascular system. J Am Heart Assoc. 2017;6: e006353. DOI: 10.1161/JAHA.117.006353.
7. Knura M, Dragon J, Labuzek K, Okopien B. [The impact of electronic cigarettes usage on the endothelial function and the progression of atherosclerosis]. Pol Merkur Lekarski. 2018;44: 26-30.
8. Glantz SA, Bareham DW. E-cigarettes: use, effects on smoking, risks, and policy implications. Annu Rev Public Health. 2018;39: 215-235.
9. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129: 1972-1986.
10. Margham J, McAdam K, Forster M, Liu C, Wright C, Mariner D, Proctor C. Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chem Res Toxicol. 2016;29: 1662-1678.
11. Szoltysek-Boldys I, Sobczak A, Zielinska-Danch W, Barton A, Koszowski B, Kosmider L. Influence of inhaled nicotine source on arterial stiffness. Przegl Lek. 2014;71: 572-575.
12. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V. Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardiovasc Disord. 2014;14: 78.
13. Lundbäck M, Antoniewicz L, Brynedal A, Bosson J. Acute effects of active ecigarette inhalation on arterial stiffness. Eur Respir J. 2017. Available at: http://erj.ersjournals.com/content/50/suppl_61/OA1979. Accessed July 4, 2018.
14. Olfert IM, DeVallance E, Hoskinson H, Branyan KW, Clayton S, Pitzer CR, Sullivan DP, Breit MJ, Wu ZX, Klinkhachorn P, Mandler WK, Erdreich BH, Ducatman BS, Bryner RW, Dasgupta P, Chantler PD. Chronic exposure to electronic cigarette (e-cig) results in impaired cardiovascular function in mice. J Appl Physiol (1985). 2018;124: 573-582.
15. Schweitzer KS, Chen SX, Law S, Van Demark M, Poirier C, Justice MJ, Hubbard WC, Kim ES, Lai X, Wang M, Kranz WD, Carroll CJ, Ray BD, Bittman R, Goodpaster J, Petrache I. Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures. Am J Physiol Lung Cell Mol Physiol. 2015;309: L175-L187.
16. Hom S, Chen L, Wang T, Ghebrehiwet B, Yin W, Rubenstein DA. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations. Platelets. 2016;27: 694-702.
17. Barua RS, Ambrose JA. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol. 2013;33: 1460-1467.
18. Salahuddin S, Prabhakaran D, Roy A. Pathophysiological mechanisms of tobacco-related CVD. Glob Heart. 2012;7: 113-120.
19. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43: 1731-1737.
20. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res. 1999;93: 271-278.
21. Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, Margosan D, Ambrose JA. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation. Arterioscler Thromb Vasc Biol. 2010;30: 75-79.
22. Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, Margosan D, Aftab W, Ambrose JA. Acute cigarette smoke exposure reduces clot lysis-association between altered fibrin architecture and the response to t-PA. Thromb Res. 2010;126: 426-430.
23. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation. 2004;109: 78-83.
24. Robinson RJ, Hensel EC, Morabito PN, Roundtree KA. Electronic cigarette topography in the natural environment. PLoS One. 2015;10: e0129296.
25. Lauterstein DE, Tijerina PB, Corbett K, Akgol Oksuz B, Shen SS, Gordon T, Klein CB, Zelikoff JT. Frontal cortex transcriptome analysis of mice exposed to electronic cigarettes during early life stages. Int J Environ Res Public Health. 2016;13: 417.
26. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: implications for research protocol standards definition and for public health authorities’ regulation. Int J Environ Res Public Health. 2013;10: 2500-2514.
27. Behar RZ, Hua M, Talbot P. Puffing topography and nicotine intake of electronic cigarette users. PLoS One. 2015;10: e0117222.
28. Flora JW, Wilkinson CT, Wilkinson JW, Lipowicz PJ, Skapars JA, Anderson A, Miller JH. Method for the determination of carbonyl compounds in e-cigarette aerosols. J Chromatogr Sci. 2017;55: 142-148.
29. Etter JF, Bullen C. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction. 2011;106: 2017-2028.
30. Cunningham A, Slayford S, Vas C, Gee J, Costigan S, Prasad K. Development, validation and application of a device to measure e-cigarette users’ puffing topography. Sci Rep. 2016;6: 35071.
31. Evans SE, Hoffman AC. Electronic cigarettes: abuse liability, topography and subjective effects. Tob Control. 2014;23(suppl 2): ii23-ii29.
32. Robinson RJ, Hensel EC, Roundtree KA, Difrancesco AG, Nonnemaker JM, Lee YO. Week long topography study of young adults using electronic cigarettes in their natural environment. PLoS One. 2016;11: e0164038.
33. Lee YO, Nonnemaker JM, Bradfield B, Hensel EC, Robinson RJ. Examining daily electronic cigarette puff topography among established and nonestablished cigarette smokers in their natural environment. Nicotine Tob Res. 2017. Available at: https://academic.oup.com/ntr/advance-article-abstrac t/doi/10.1093/ntr/ntx222/4344908?redirectedFrom=fulltext. Accessed July 4, 2018.
34. Barrington-Trimis JL, Gibson LA, Halpern-Felsher B, Harrell MB, Kong G, Krishnan-Sarin S, Leventhal AM, Loukas A, McConnell R, Weaver SR. Type of e-cigarette device used among adolescents and young adults: findings from a pooled analysis of eight studies of 2166 vapers. Nicotine Tob Res. 2018;20: 271-274.
35. Brown CJ, Cheng JM. Electronic cigarettes: product characterisation and design considerations. Tob Control. 2014;23: ii4-ii10.
36. Chen Z, Zeng DD. Mining online e-liquid reviews for opinion polarities about e-liquid features. BMC Public Health. 2017;17: 633.
37. Kaisar MA, Kallem RR, Sajja RK, Sifat AE, Cucullo L. A convenient UHPLCMS/ MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse. BMC Neurosci. 2017;18: 71.
38. Karim ZA, Alshbool FZ, Vemana HP, Adhami N, Dhall S, Espinosa EV, Martins-Green M, Khasawneh FT. Third-hand smoke: impact on hemostasis and thrombogenesis. J Cardiovasc Pharmacol. 2015;66: 177-182.
39. Hensch NR, Karim ZA, Pineda J, Mercado N, Alshbool FZ, Khasawneh FT. P2y12 antibody inhibits platelet activity and protects against thrombogenesis. Biochem Biophys Res Commun. 2017;493: 1069-1074.
40. Alshbool FZ, Karim ZA, Vemana HP, Conlon C, Lin OA, Khasawneh FT. The regulator of G-protein signaling 18 regulates platelet aggregation, hemostasis and thrombosis. Biochem Biophys Res Commun. 2015;462: 378-382.
41. Hensch NR, Karim ZA, Druey KM, Tansey MG, Khasawneh FT. RGS10 negatively regulates platelet activation and thrombogenesis. PLoS One. 2016;11: e0165984.
42. Karim ZA, Alshbool FZ, Vemana HP, Conlon C, Druey KM, Khasawneh FT. CXCL12 regulates platelet activation via the regulator of G-protein signaling 16. Biochim Biophys Acta. 2016;1863: 314-321.
43. Scott DA, Palmer RM. The influence of tobacco smoking on adhesion molecule profiles. Tob Induc Dis. 2002;1: 7-25.
44. Whitehead TP, Robinson D, Allaway SL, Hale AC. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin Lab Haematol. 1995;17: 131-138.
45. Velez de Mendizabal N, Jones DR, Jahn A, Bies RR, Brown JW. Nicotine and cotinine exposure from electronic cigarettes: a population approach. Clin Pharmacokinet. 2015;54: 615-626.
46. McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, Neptune E, Klein JD, Winickoff JP, Breysse P, Lazarus P, Chen G. The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One. 2015;10: e0118344.
47. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, Koutedakis Y. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25: 91-101.
48. Etter JF. A longitudinal study of cotinine in long-term daily users of ecigarettes. Drug Alcohol Depend. 2016;160: 218-221.
49. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost. 2009;7: 1297-1303.
50. Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation. 1973;48: 619-623.
51. Gitte RN. Effect of cigarette smoking on plasma fibrinogen and platelet count. Asian Journal of Medical Sciences. 2012;2: 181-184.
52. Suwansaksri J, Wiwanitkit V, Soogarun S. Effect of smoking on platelet count and platelet parameters: an observation. Clin Appl Thromb Hemost. 2004;10: 287-288.
53. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med. 1989;149: 386-389.
54. Dawood BB, Wilde J, Watson SP. Reference curves for aggregation and ATP secretion to aid diagnosis of platelet-based bleeding disorders: effect of inhibition ofADPand thromboxaneA(2) pathways. Platelets. 2007;18: 329-345.
55. Storrie B, Whiteheart SW. Editorial: platelet secretion. Platelets. 2017;28: 107.
56. 3. J Clin Invest. 2005;115: 3363-3369.
57. Schoenwaelder SM, Yuan Y, Josefsson EC, White MJ, Yao Y, Mason KD, O’Reilly LA, Henley KJ, Ono A, Hsiao S, Willcox A, Roberts AW, Huang DC, Salem HH, Kile BT, Jackson SP. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114: 663-666.
58. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89: 1121-1132.
59. Kuypers FA. Phospholipid asymmetry in health and disease. Curr Opin Hematol. 1998;5: 122-131.
60. Senis YA, Sangrar W, Zirngibl RA, Craig AWB, Lee DH, Greer PA. Fps/Fes and Fer non-receptor protein-tyrosine kinases regulate collagen- and ADPinduced platelet aggregation. J Thromb Haemost. 2003;1: 1062-1070.
61. Stojanovic A, Marjanovic JA, Brovkovych VM, Peng X, Hay N, Skidgel RA, Du X. A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation. J Biol Chem. 2006;281: 16333-16339.
62. Kwon HW, Shin JH, Lee DH, Park HJ. Inhibitory effects of cytosolic Ca(2+) concentration by ginsenoside RO are dependent on phosphorylation of IP3RI and dephosphorylation of ERK in human platelets. Evid Based Complement Alternat Med. 2015;2015: 764906.
63. Woulfe D, Jiang H, Morgans A, Monks R, Birnbaum M, Brass LF. Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking AKT2. J Clin Invest. 2004;113: 441-450.
64. Garcia A, Quinton TM, Dorsam RT, Kunapuli SP. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIbinduced fibrinogen receptor activation in human platelets. Blood. 2005;106: 3410-3414.
65. Kaisar MA, Prasad S, Liles T, Cucullo L. A decade of e-cigarettes: limited research & unresolved safety concerns. Toxicology. 2016;365: 67-75.
66. Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 surgeon general’s report: “The health consequences of smoking-50 years of progress”: a paradigm shift in cancer care. Cancer. 2014;120: 1914-1916.
67. Pepper JK, Brewer NT. Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review. Tob Control. 2014;23: 375-384.
68. King BA, Alam S, Promoff G, Arrazola R, Dube SR. Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013;15: 1623-1627.
69. Centers for Disease C, Prevention. Notes from the field: electronic cigarette use among middle and high school students-United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2013;62: 729-730.
70. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: adult use and awareness of the “e-cigarette” in the USA. Tob Control. 2013;22: 19-23.
71. Breit M, Hoskinson H, Pitzer C, Wu Z, Bryner R, Olfert IM. Effects of electronic cigarette vapor on body mass, food intake, and body composition. FASEB J. 2017;31: 1037.
72. Zhang G, Wang Z, Zhang K, Hou R, Xing C, Yu Q, Liu E. Safety assessment of electronic cigarettes and their relationship with cardiovascular disease. Int J Environ Res Public Health. 2018;15: E75.
73. Zhu S-H, Sun JY, Bonnevie E, Cummins SE, Gamst A, Yin L, Lee M. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23: iii3-iii9.
74. Xu X, Su Y, Fan ZH. Cotinine concentration in serum correlates with tobacco smoke-induced emphysema in mice. Sci Rep. 2014;4: 3864.
75. Churg A, Wright JL. Animal models of cigarette smoke-induced chronic obstructive lung disease. Contrib Microbiol. 2007;14: 113-125.
76. Morissette MC, Lamontagne M, Berube JC, Gaschler G, Williams A, Yauk C, Couture C, Laviolette M, Hogg JC, Timens W, Halappanavar S, Stampfli MR, Bosse Y. Impact of cigarette smoke on the human and mouse lungs: a geneexpression comparison study. PLoS One. 2014;9: e92498.
77. Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds L-J. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107: 2342-2347.
78. Zhang S, Day I, Ye S. Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis. 2001;154: 277-283.
79. Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res. 2007;101: 654-662.
80. Shah PK. Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev. 2000;8: 31-39.
81. Matetzky S, Tani S, Kangavari S, Dimayuga P, Yano J, Xu H, Chyu KY, Fishbein MC, Shah PK, Cercek B. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation. 2000;102: 602-604.
82. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107: 973-977.
83. Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2: 71-77.
84. Smith CJ, Fischer TH, Sears SB. Environmental tobacco smoke, cardiovascular disease, and the nonlinear dose-response hypothesis. Toxicol Sci. 2000;54: 462-472.
85. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2006.
86. Bhatnagar A. Cardiovascular perspective of the promises and perils of ecigarettes. Circ Res. 2016;118: 1872-1875.
87. Pieri L, Chellini E, Gorini G. [Smoking fewer cigarettes per day may determine a significant risk reduction in developing smoking attributable diseases? Is there a risk reduction for e-cigarette users?]. Epidemiol Prev. 2014;38: 390-393.
88. Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22(suppl B): 72B-80B.
89. Temesgen N, Pena I, Tayeb T, Alzahrani T. A cross sectional study reveals an association between electronic cigarette use and myocardial infarction. J Hosp Med. 2017;12:(suppl 2): 100.
90. Kivrak T, Sunbul M, Durmus E, Dervisova R, Sari I, Yesildag O. Acute myocardial infarction due to liquid nicotine in a young man. Ther Adv Cardiovasc Dis. 2014;8: 32-34.
91. Lee HW, Park SH, Weng MW, Wang HT, Huang WC, Lepor H, Wu XR, Chen LC, Tang MS. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci USA. 2018;115: E1560-E1569.
92. Kaisar MA, Villalba H, Prasad S, Liles T, Sifat AE, Sajja RK, Abbruscato TJ, Cucullo L. Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: is metformin a viable countermeasure? Redox Biol. 2017;13: 353-362.
93. Sithu SD, Srivastava S, Siddiqui MA, Vladykovskaya E, Riggs DW, Conklin DJ, Haberzettl P, O’Toole TE, Bhatnagar A, D’Souza SE. Exposure to acrolein by inhalation causes platelet activation. Toxicol Appl Pharmacol. 2010;248: 100-110.
94. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111: 2684-2698.
95. Sinzinger H, Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet. 1982;2: 392-393.
96. Jin J, Mao Y, Thomas D, Kim S, Daniel JL, Kunapuli SP. RhoA downstream of G (q) and G(12/13) pathways regulates protease-activated receptor-mediated dense granule release in platelets. Biochem Pharmacol. 2009;77: 835-844.
97. Kim S, Jin J, Kunapuli SP. Akt activation in platelets depends on Gi signaling pathways. J Biol Chem. 2004;279: 4186-4195.
98. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, Harris C, Belinsky S, Dennis PA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 2003;111: 81-90.
99. Dajas-Bailador FA, Soliakov L, Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the a7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J Neurochem. 2002;80: 520-530.
100. Brunzell DH, Russell DS, Picciotto MR. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57BL/6J mice. J Neurochem. 2003;84: 1431-1441.
101. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23: ii11-ii17.
102. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jorres RA, Fromme H. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. 2014;217: 628-637.
103. Williams M, Villarreal A, Bozhilov K, Lin S, Talbot P. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013;8: e57987.
104. Fernandez E, Ballbe M, Sureda X, Fu M, Salto E, Martinez-Sanchez JM. Particulate matter from electronic cigarettes and conventional cigarettes: a systematic review and observational study. Curr Environ Health Rep. 2015;2: 423-429.
105. Hioki H, Aoki N, Kawano K, Homori M, Hasumura Y, Yasumura T, Maki A, Yoshino H, Yanagisawa A, Ishikawa K. Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J. 2001;22: 56-61.
106. Fahim MA, Nemmar A, Singh S, Hassan MY. Antioxidants alleviate nicotineinduced platelet aggregation in cerebral arterioles of mice in vivo. Physiol Res. 2011;60: 695-700.
107. Girdhar G, Xu S, Bluestein D, Jesty J. Reduced-nicotine cigarettes increase platelet activation in smokers in vivo: a dilemma in harm reduction. Nicotine Tob Res. 2008;10: 1737-1744.
108. Ljungberg LU, Persson K, Eriksson AC, Green H, Whiss PA. Effects of nicotine, its metabolites and tobacco extracts on human platelet function in vitro. Toxicol In Vitro. 2013;27: 932-938.
109. Wilson DW, Aung HH, Lame MW, Plummer L, Pinkerton KE, Ham W, Kleeman M, Norris JW, Tablin F. Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation. Inhal Toxicol. 2010;22: 267-276.
110. Mutlu GM, Green D, Bellmeyer A, Baker CM, Burgess Z, Rajamannan N, Christman JW, Foiles N, Kamp DW, Ghio AJ, Chandel NS, Dean DA, Sznajder JI, Budinger GR. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest. 2007;117: 2952-2961.